Hugh Y. Rienhoff, Jr. M.D.

Laura G. Eichorn

Jennifer Peppe

Amy E. Tapper, Ph.D.

Matthew Plunkett, Ph.D.

Hugh Y. Rienhoff, Jr. M.D.

Chief Executive Officer

Dr. Rienhoff is a San Francisco Bay area clinical physician-scientist and entrepreneur. He was a founding director of Healtheon/WebMD (HLTH) and Aurora Biosciences (ABSC). In 1998 he founded DNA Sciences (originally Kiva Genetics) and served as its Chairman and Chief Executive Officer Dr. Rienhoff founded and was Chief Executive Officer of FerroKin BioSciences from 2007 until its acquisition by Shire Pharmaceuticals in 2012. Dr. Rienhoff is the Chief Executive Officer and a founder of Imago BioSciences.

Dr. Rienhoff trained in mathematics, medicine, and genetics at Harvard University, Johns Hopkins University, and the Fred Hutchinson Cancer Research Center in Seattle, Washington. He received a Doctor of Medicine degree from Johns Hopkins University School of Medicine and a Bachelor of Arts degree in Biology and English Literature from Williams College.

We are an international private company found and led by the team of investors, managers and entrepreneurs.

© 2014 Imago BioSciences. All rights reserved.
Disclaimer: Imago Biosciences™ is in no way affiliated with Imago Pharmaceuticals™.